Summit signals EMED sale for $190m

The Boston firm agrees to sell the sign maker to Brady Corp. and also completes a co-investment with Berkshire in radiological protection services company Bartlett Nuclear.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this